![Jon Resnick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 286 651 $ al 31/07/2026
Jon Resnick is Chief Executive Officer & Director at Certara, Inc. since 2026.
Mr. Resnick is President-United States & Canada at IQVIA, Inc. since 2019.
Formerly, Mr. Resnick was President-Real World & Analytics Solutions at IQVIA Holdings, Inc. Mr. Resnick completed undergraduate studies at Union College (New York) and earned an MBA from Kellogg School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CERTARA, INC. 0,02 % | 11/05/2026 | 35.389 ( 0,02 % ) | 286 651 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMS HEALTH, INC. | Presidente | 01/07/2019 |
| CERTARA, INC. | Director Ejecutivo | 01/01/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| IQVIA HOLDINGS INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
IQVIA, Inc.
 IQVIA, Inc. Packaged SoftwareTechnology Services Provides AI assistant, analytics and clinical research services for healthcare sector | Technology Services |
Union College (New York)
 Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IQVIA Holdings, Inc.
 IQVIA Holdings, Inc. BiotechnologyHealth Technology Provides outsourced clinical research and trial, mission critical information, technology, healthcare and patient engagement services | Health Technology |
Certara, Inc.
 Certara, Inc. Packaged SoftwareTechnology Services Develops bio simulation software and technology to transform traditional drug discovery and development | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
